|
|
|
197A TAUNS Laboratories,Inc.
|
|
| 11/12/2026 13:30 |
Notice Concerning the Execution of a Capital and Business Alliance Agreement with Kurabo Industries Ltd., the Secondary Offering of Shares, and Change |
| 11/12/2026 13:30 |
Financial Highlights for 1st Quarter ended September 30, 2026 of FY2027 |
| 11/12/2026 13:30 |
Consolidated Financial Results for the Three Months Ended September 30, 2026 (Japanese Accounting Standards) |
| 09/02/2026 08:00 |
Notice of the 11th Ordinary General Meeting of Shareholders |
| 08/26/2026 15:30 |
Notice Concerning Partial Amendments to the Articles of Incorporation |
| 08/26/2026 15:30 |
Notice Concerning Transition to a Company with an Audit and Supervisory Committee and Changes in Directors |
| 08/20/2026 16:00 |
Notice Concerning Capital and Business Alliance with Asia Pathogenomics Co., Ltd |
| 08/18/2026 15:30 |
Notice Concerning Craif's Series D Financing with TAUNS Laboratories as a Co-Lead Investor |
| 08/13/2026 15:30 |
Financial Highlights for FY ended June 30,2026 |
| 08/13/2026 15:30 |
FY2026 Financial Results (Japanese Accounting Standards) |
| 08/13/2026 15:30 |
Notice Concerning Recognition of Special Gains (Government Subsidy) |
| 08/06/2026 15:30 |
Notice of Participation in the ASAGI Labs Longevity Consortium |
| 07/15/2026 18:30 |
Notice of Basic Agreement on Capital and Business Alliance with Splink, Inc. |
| 07/15/2026 18:30 |
Notice of Basic Agreement on Capital and Business Alliance with Callisto Inc |
| 07/15/2026 18:30 |
Notice of Basic Agreement on Capital and Business Alliance with Provigate, Inc |
| 07/15/2026 18:30 |
Notice Concerning Update to Mid-Term Management Plan |
| 07/08/2026 15:30 |
Notice Concerning the Execution of a Business Alliance Agreement with Craif, Inc. |
| 06/30/2026 15:30 |
Notice of Organizational Changes and Personnel Changes |
| 05/14/2026 15:30 |
Financial Highlights for 3Q ended March 31, 2026 of FY2026 |
| 05/14/2026 15:30 |
Financial Results for the Nine Months Ended March 31, 2026 (Japanese Accounting Standards) |
| 03/30/2026 15:30 |
Notice Concerning Revision of Full-Year Earnings Forecast |
| 02/13/2026 15:30 |
Financial Highlights for 2Q ended December 31, 2025 of FY2026 |
| 02/13/2026 15:30 |
Financial Results for the SIX Months Ended December 31, 2025 (Japanese Accounting Standards) |
| 02/02/2026 16:00 |
Full-Scale Operation Begins at Fujisan Mishima Factory |
| 12/15/2025 15:30 |
TAUNS Laboratories, Inc. has Concluded a Capital and Business Alliance Agreement with EMC Healthcare Co., Ltd |
| 11/27/2025 17:00 |
Notice Regarding Acquisition of Shares in CLAIRVO TECHNOLOGIES, Inc. (Making it a Subsidiary) |
|